JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M106966200 on November 15, 2001

J. Biol. Chem., Vol. 277, Issue 3, 1967-1973, January 18, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/3/1967    most recent
M106966200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manohar, C. F.
Right arrow Articles by Cohn, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manohar, C. F.
Right arrow Articles by Cohn, S. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HuD, a Neuronal-specific RNA-binding Protein, Increases the in Vivo Stability of MYCN RNA*

Chitra F. ManoharDagger , Marc L. ShortDagger §, Anthony NguyenDagger , Nadine N. NguyenDagger , Daniel ChagnovichDagger , Qiwei YangDagger , and Susan L. Cohn||**

From the || Department of Pediatrics and Dagger  The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, Illinois 60611

MYCN amplification and consequent deregulated expression plays a crucial role in determining the clinical behavior of neuroblastoma. Enhanced expression of MYCN confers growth potential to neuroblastoma cells, and a direct link between MYCN expression and the development of neuroblastoma has been demonstrated in transgenic mice studies. Although the molecular pathways underlying the regulation of MYCN have not been fully elucidated, post-transcriptional mechanisms appear to be important. Previously, we reported that an embryonic lethal abnormal vision-like (ELAV) protein binds with high specificity to at least two AU-rich elements within the MYCN 3'-untranslated region. In this study, we characterized the ability of cis-acting elements within the MYCN 3'-untranslated region to destabilize mRNA in cells and examined the functional consequences of its interactions with the ELAV protein HuD. We show that at least 4 cis-acting elements within the MYCN 3'-untranslated region are able to signal the degradation of stable heterologous mRNA. Ectopic overexpression of HuD dramatically inhibits RNA decay mediated by the full-length MYCN 3'-untranslated region and cis-acting destabilizing elements that harbor HuD binding sites in vivo. HuD may contribute to the malignant phenotype of neuroblastoma cells by stabilizing MYCN mRNA, thereby enhancing steady-state levels of expression of this oncogene.

* This work was supported by NCI, National Institutes of Health (NIH) Grant CA74824, the Elise Anderson Neuroblastoma Research Fund, the Neuroblastoma Children's Cancer Society, gifts from Dennis Drescher, and the Robert H. Lurie Comprehensive Cancer Center, NCI, NIH Core Grant 5P30CA60553.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Current address: Applied Biosystems, 850 Lincoln Center Dr., Foster City, CA 94404.

Current address: Skirball Institute, 540 1st Ave., New York, NY 10016.

** To whom correspondence should be addressed: Children's Memorial Hospital, Division of Hematology/Oncology, Box 30, 2300 Children's Plaza, Chicago, IL 60614. Tel.: 773-880-4562; Fax: 773-880-3053; E-mail: scohn@northwestern.edu.

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
Q. Yang, Y. Tian, S. Liu, R. Zeine, A. Chlenski, H. R. Salwen, J. Henkin, and S. L. Cohn
Thrombospondin-1 Peptide ABT-510 Combined with Valproic Acid Is an Effective Antiangiogenesis Strategy in Neuroblastoma
Cancer Res., February 15, 2007; 67(4): 1716 - 1724.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Gupta, B. R.G. Williams, S. M. Hanash, and J. Rawwas
Cellular Retinoic Acid-Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma
Cancer Res., August 15, 2006; 66(16): 8100 - 8108.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W.-W. Ge, W. Wen, W. Strong, C. Leystra-Lantz, and M. J. Strong
Mutant Copper-Zinc Superoxide Dismutase Binds to and Destabilizes Human Low Molecular Weight Neurofilament mRNA
J. Biol. Chem., January 7, 2005; 280(1): 118 - 124.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
S. Boy, J. Souopgui, M. A. Amato, M. Wegnez, T. Pieler, and M. Perron
XSEB4R, a novel RNA-binding protein involved in retinal cell differentiation downstream of bHLH proneural genes
Development, February 15, 2004; 131(4): 851 - 862.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Pascale, P. A. Gusev, M. Amadio, T. Dottorini, S. Govoni, D. L. Alkon, and A. Quattrone
Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory
PNAS, February 3, 2004; 101(5): 1217 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Park-Lee, S. Kim, and I. A. Laird-Offringa
Characterization of the Interaction between Neuronal RNA-binding Protein HuD and AU-rich RNA
J. Biol. Chem., October 10, 2003; 278(41): 39801 - 39808.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q.-W. Yang, S. Liu, Y. Tian, H. R. Salwen, A. Chlenski, J. Weinstein, and S. L. Cohn
Methylation-associated Silencing of the Thrombospondin-1 Gene in Human Neuroblastoma
Cancer Res., October 1, 2003; 63(19): 6299 - 6310.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Deschenes-Furry, G. Belanger, N. Perrone-Bizzozero, and B. J. Jasmin
Post-transcriptional Regulation of Acetylcholinesterase mRNAs in Nerve Growth Factor-treated PC12 Cells by the RNA-binding Protein HuD
J. Biol. Chem., February 14, 2003; 278(8): 5710 - 5717.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Chlenski, S. Liu, S. E. Crawford, O. V. Volpert, G. H. DeVries, A. Evangelista, Q. Yang, H. R. Salwen, R. Farrer, J. Bray, et al.
SPARC Is a Key Schwannian-derived Inhibitor Controlling Neuroblastoma Tumor Angiogenesis
Cancer Res., December 15, 2002; 62(24): 7357 - 7363.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Kasashima, E. Sakashita, K. Saito, and H. Sakamoto
Complex formation of the neuron-specific ELAV-like Hu RNA-binding proteins
Nucleic Acids Res., October 15, 2002; 30(20): 4519 - 4526.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.